2013_17_Biotech_IPOs.xlsx
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

 
View only
 
 
ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
BiotechIPO DateHeadquartersTickerShs SoldIPO $/ShIPO ProceedsInsider %Insider DollarsInsider Optional
SEC Link
Date FoundedPre-IPO SharesIPO Pre- MoneyShs Post-IPOPost IPO Mkt CapMost AdvancedPlatformPlatform TypeTherapeutic Area
2
Denali Therapeutics07-Dec-17NorCalDNLI13.89$18.00$250.0238.2%$95.51Link201374.11$1,334.088.0$1,584.00Phase IDrug designSMDMOA CNS
3
Odonate Therapeutics06-Dec-17SoCalODT6.25$24.00$150.0027.3%$40.95Link201320.65$495.626.9$645.60Phase IIINoneChemotherapy
4
Quanterix06-Dec-17MassQRTX4.28$15.00$64.1325.1%$16.10Link200716.93$253.921.2$318.00MktDiagnostic
5
Arsanis20-Nov-17MassASNS4.00$10.00$40.0050.0%$20.00YesLink20109.70$97.013.7$137.00Phase IIMonoclonalsPAVMOA Infection
6
scPharmaceuticals16-Nov-17MassSCPH6.40$14.00$89.6039.1%$35.03Link201311.20$156.817.6$246.40FiledDrug deliveryCardiovascular
7
Erytech Pharma09-Nov-17ERYP5.37$22.82$122.6361.4%$75.30Link200411.73$267.617.1$390.22Phase IIIrare diseasesGOCancer
8
Apellis Pharm08-Nov-17APLS10.71$14.00$150.0033.8%$50.70YesLink200938.59$540.249.3$690.20Phase IINoneMOA inflammation
9
InflaRx07-Nov-17IFRX6.67$15.00$100.0150.0%$50.00YesLink200716.73$251.023.4$351.00Phase IIMonoclonalsPAVMOA inflammation
10
Allena Pharm01-Nov-17MassALNA5.33$14.00$74.6226.8%$20.00YesLink201115.27$213.820.6$288.40Phase IIrare diseasesGOMetabolic diseases
11
Spero Therapeutics01-Nov-17MassSPRO5.50$14.00$77.0039.0%$30.03YesLink20138.40$117.613.9$194.60Phase IINoneInfection
12
Ablynx24-Oct-17ABLX11.43$17.50$200.03Link200161.47$1,075.772.9$1,275.75Phase IIIMonoclonalsPAVBlood disorders
13
Genprex13-Oct-17GNPX4.50$5.00$22.50Link200911.70$58.516.2$81.00Phase IIGene TherapyIOCGMOA cancer
14
OptiNose12-Oct-17OPTN7.50$16.00$120.0016.7%$20.04Link201029.10$465.636.6$585.60MktDrug deliveryAllergy
15
Rhythm Pharm04-Oct-17MassRYTM7.05$17.00$119.8520.9%$25.05Link200819.05$323.926.1$443.70Phase IIIPeptidesPAVMetabolic diseases
16
Deciphera Pharm27-Sep-17MassDCPH7.50$17.00$127.5020.3%$25.88Link201524.40$414.831.9$542.30Phase IDrug designSMDMOA cancer
17
Nightstar Therapeutics27-Sep-17NITE5.36$14.00$75.0446.0%$34.52Link201622.74$318.428.1$393.40Phase IGene TherapyIOCGEye diseases
18
NuCana27-Sep-17NCNA6.67$15.00$100.0114.0%$14.00Link199724.23$363.530.9$463.50Phase IIDrug designSMDChemotherapy
19
Zai Lab20-Sep-17ZLAB8.33$18.00$149.9412.3%$18.44Link201340.97$737.549.3$887.40Phase IINone
Cancer & Autoimmune
20
Celcuity19-Sep-17CELC2.40$9.50$22.80Link20127.30$69.49.7$92.15MktDiagnostic
21
Krystal Biotech19-Sep-17KRYS3.96$10.00$39.602.5%$0.99Link20165.64$56.49.6$96.00PreclinicalGene TherapyIOCGDermatology
22
Zealand Pharma08-Aug-17ZEAL4.38$17.87$78.18Link199726.23$468.630.6$546.82MktPeptidesPAVDiabetes
23
Clementia Pharm01-Aug-17CMTA8.00$15.00$120.007.5%$9.00Link201022.50$337.530.5$457.50Phase IISmall moleculesSMDBone diseases
24
Sienna Biopharm26-Jul-17SoCalSNNA4.33$15.00$64.9532.3%$20.98Link201015.57$233.619.9$298.50Phase IIDrug designSMDDermatology
25
Kala Pharm19-Jul-17MassKALA6.00$15.00$90.0044.4%$39.96YesLink200917.30$259.523.3$349.50Phase IIISmall moleculesSMDEye diseases
26
Akcea Therapeutics13-Jul-17MassAKCA25.00$8.00$200.0037.5%$75.00Link201439.20$313.664.2$513.60Phase IIIAntisenseIOCGLipid disorders
27
Co-Diagnostics12-Jul-17CODX1.18$6.00$7.07Link20139.92$59.511.1$66.60MktDiagnostic
28
Aileron Therapeutics28-Jun-17MassALRN3.75$15.00$56.2544.4%$24.98YesLink200110.95$164.314.7$220.50Phase IIPeptidesPAVMOA cancer
29
Dova Pharm28-Jun-17DOVA4.42$17.00$75.0622.8%$17.11Link201620.59$349.925.0$425.00Phase IIINoneBlood disorders
30
Mersana Therapeutics27-Jun-17MassMRSN5.00$15.00$75.0037.3%$27.98Link200217.70$265.522.7$340.50Phase IMonoclonalsPAVMOA cancer
31
Avenue Therapeutics26-Jun-17ATXI5.50$6.00$33.00Link20153.30$19.88.8$52.80Phase IIDrug deliveryPain
32
Athenex13-Jun-17ATNX6.00$11.00$66.0083.3%$54.98Link200350.00$550.056.0$616.00Phase IIIDrug designSMDMOA cancer
33
argenx17-May-17ARGX5.87$17.00$99.71Link200820.14$342.326.0$442.00Phase IIMonoclonalsPAVAutoimmune
34
G1 Therapeutics16-May-17GTHX7.00$15.00$105.0034.1%$35.81Link200820.40$306.027.4$411.00Phase IINoneMOA cancer
35
ENDRA Life Sciences08-May-17NDRA1.68$5.00$8.40Link20071.92$9.63.6$18.00MktDiagnostic
36
Ovid Therapeutics04-May-17OVID5.00$15.00$75.0026.7%$20.03YesLink201419.60$294.024.6$369.00Phase IIrare diseasesGOCNS
37
Biohaven Pharm03-May-17BHVN9.90$17.00$168.3031.7%$53.35Link201324.30$413.134.2$581.40Phase IISmall moleculesSMDCNS
38
UroGen Pharma03-May-17URGN4.47$13.00$58.1534.4%$20.00YesLink20047.53$97.912.0$156.00Phase IINoneChemotherapy
39
Zymeworks27-Apr-17ZYME4.50$13.00$58.5067.0%$39.20Link200320.40$265.224.9$323.70Phase IMonoclonalsPAVMOA cancer
40
Verona Pharma26-Apr-17VRNA47.40$1.63$77.26Link200551.60$84.199.0$161.37Phase IINoneRespiratory
41
Tocagen12-Apr-17SoCalTOCA8.50$10.00$85.00Link200710.00$100.018.5$185.00Phase IIGene TherapyIOCGCancer
42
BeyondSpring08-Mar-17BYSI2.72$20.00$54.4093.4%$50.81Link201418.98$379.621.7$434.00Phase IISmall moleculesSMDCancer
43
Jounce Therapeutics26-Jan-17MassJNCE6.37$16.00$101.849.8%$9.98YesLink201224.84$397.431.2$499.20Phase IIImmunotherapyIOCGMOA cancer
44
AnaptysBio25-Jan-17SoCalANAB5.00$15.00$75.0038.9%$29.18Link200514.20$213.019.2$288.00Phase IMonoclonalsPAVInflammation
45
ObsEva25-Jan-17OBSV6.45$15.00$96.7564.4%$62.31Link201223.15$347.329.6$444.00Phase IIWomen's healthMenstrual bleeding
46
TiGenix14-Dec-16TIG46.00$0.78$35.65Link2000202.30$156.8248.3$192.43Filedcell therapyIOCGCrohn's disease
47
SenesTech08-Dec-16SNES1.88$8.00$15.00Link20048.23$65.810.1$80.80FiledPest controlFertility control
48
Motif Bio17-Nov-16MTFB71.60$0.35$25.0625.0%$6.27Link2003109.00$38.2180.6$63.21Phase IIINoneAntibiotics
49
Myovant26-Oct-16MYOV14.50$15.00$217.5027.6%$60.03Link201645.70$685.560.2$903.00Phase IISmall moleculesSMDWomen's health
50
Ra Pharmaceuticals25-Oct-16MassRARX7.05$13.00$91.65Link200814.45$187.921.5$279.50Phase IIPeptidesPAVInflammation
51
CRISPR Therapeutics18-Oct-16CRSP6.50$14.00$91.0038.5%$35.04Link201335.40$495.641.9$586.60PreclinicalGene therapyIOCGBlood disorders
52
AzurRx BioPharma11-Oct-16AZRX0.96$5.50$5.28Link20149.04$49.710.0$55.00Phase IBiologicsPAVGI disorders
53
Fulgent Genetics28-Sep-16SoCalFLGT4.20$9.00$37.8023.8%$9.00Link201112.80$115.217.0$153.00MktDiagnosticGenetic testing
54
AC Immune22-Sep-16ACIU6.00$11.00$66.0031.7%$20.92Link200349.40$543.455.4$609.40Phase IIMonoclonalsPAVMAB CNS
55
Novan20-Sep-16NOVN4.10$11.00$45.1039.9%$17.99Link200611.20$123.215.3$168.30Phase IIINitric oxideDerm
56
Protagonist Therapeutics
10-Aug-16NorCalPTGX7.50$12.00$90.0045.3%$40.77Link20018.80$105.616.3$195.60Phase IOral peptidesPAVPeptides
57
Gemphire Therapeutics04-Aug-16GEMP3.00$10.00$30.0033.0%$9.90YesLink20085.40$54.08.4$84.00Phase IISmall moleculesSMDCardio
58
Kadmon Holdings26-Jul-16KDMN6.25$12.00$75.0053.3%$39.98YesLink201038.65$463.844.9$538.80Phase IISmall moleculesSMDFibrosis
59
Audentes Therapeutics19-Jul-16NorCalBOLD5.00$15.00$75.0022.5%$16.88Link201215.00$225.020.0$300.00PreclinicalGene therapyIOCGGenetic diseases
60
Syros Pharmaceuticals29-Jun-16MassSYRS4.00$12.50$50.0070.0%$35.00YesLink201118.80$235.022.8$285.00Phase IISmall moleculesSMDMOA cancer
61
Selecta Biosciences27-Jun-16MassSELB5.00$14.00$70.0057.1%$39.97YesLink200712.90$180.617.9$250.60Phase IImmunotherapyIOCGNanoparticles
62
Clearside Biomedical01-Jun-16CLSD7.20$7.00$50.4054.5%$27.47Link201112.40$86.819.6$137.20Phase IIINoneOphthalmic
63
Reata Pharmaceuticals25-May-16RETA5.50$11.00$60.5048.3%$29.22Link200216.00$176.021.5$236.50Phase IIISmall moleculesSMDMitochondria
64
Merus N.V.18-May-16MRUS5.50$10.00$55.0059.1%$32.51YesLink20039.90$99.015.4$154.00Phase IImmunotherapyIOCGBispecific Mabs
65
PhaseRx17-May-16PZRX3.70$5.00$18.5050.8%$9.40YesLink20067.90$39.511.6$58.00Preclinical
Enzyme Replacement
IOCGRNAi
66
Oncobiologics12-May-16ONS5.80$6.00$34.8057.1%$19.87Link201017.00$102.022.8$136.80Phase IBiosimilarsPAVMabs
67
Intellia Therapeutics05-May-16MassNTLA9.06$18.00$163.0861.7%$100.62Link201426.04$468.735.1$631.80PreclinicalGene therapyIOCGCRISPR
68
Spring Bank Pharm05-May-16MassSBPH0.90$12.00$10.8054.3%$5.86YesLink20026.20$74.47.1$85.20Phase IISmall oligosIOCGAntivirals
69
Moleculin Biotech02-May-16MBRX1.50$6.00$9.00Link201512.30$73.813.8$82.80Phase IINoneChemotherapy
70
Corvus Pharmaceuticals
22-Mar-16NorCalCRVS4.70$15.00$70.5030.1%$21.22Link201415.70$235.520.4$306.00Phase IImmunotherapyIOCGMOA cancer
71
Hutchison China18-Mar-16HCM3.75$27.00$101.25Link200056.55$1,526.960.3$1,628.10Phase IIIImmunotherapyIOCGMOA cancer
72
Syndax Pharmaceuticals
02-Mar-16MassSNDX4.40$12.00$52.80Link200513.00$156.017.4$208.80Phase IImmunotherapyIOCGMOA cancer
73
AveXis10-Feb-16AVXS4.75$20.00$95.0020.0%$19.00Link201017.65$353.022.4$448.00Phase IGene therapyIOCGGenetic diseases
74
Proteostasis Therapeutics
10-Feb-16MassPTI6.25$8.00$50.0040.4%$20.20Link200612.85$102.819.1$152.80Phase IScreeningRepiratory
75
Editas Medicine08-Feb-16MassEDIT5.90$16.00$94.40Link201329.80$476.835.7$571.20LeadGene therapyIOCGCRISPR
76
BeiGene02-Feb-16BGNE85.80$1.85$158.7339.8%$63.17Link2010323.90$599.2409.7$757.95Phase IIImmunotherapyIOCGMOA cancer
77
Axsome Therapeutics24-Nov-15AXSM5.67$9.00$51.03Link201213.47$121.219.1$172.26Phase IIINonePain
78
Mesoblast12-Nov-15MESO37.40$1.60$59.84Link2004337.00$539.2374.4$599.04Phase IIIcell therapyIOCGRegenerative
79
Adv Accelerator10-Nov-15AAAP9.38$8.00$75.01Link200267.77$542.277.2$617.20MktDiagnosticCancer imaging
80
Voyager Therapeutics10-Nov-15MassVYGR5.00$14.00$70.00Link201321.03$294.426.0$364.42Phase IGene TherapyIOCGCNS
81
Wave Life Sciences10-Nov-15WVE6.38$16.00$102.0060.8%$62.02YesLink201218.46$295.324.8$397.28
Preclinical
oligosIOCGMOA CNS
82
Kura Oncology04-Nov-15SoCalKURA6.25$8.00$50.00Link200714.51$116.120.8$166.08Phase IINoneMOA cancer
83
MyoKardia28-Oct-15NorCalMYOK5.44$10.00$54.4016.6%$9.03Link201220.80$208.026.2$262.40Phase Irare diseasesGOCardio
84
Oasmia Pharm28-Oct-15OASM7.02$1.35$9.48Link198897.86$132.1104.9$141.59Phase IIIDrug deliverycancer
85
Dimension Therapeutics
27-Oct-15MassDMTX5.50$13.00$71.5055.9%$39.97Link201319.38$251.924.9$323.44Phase I/IIGene TherapyIOCGHemophilia
86
Strongbridge Biopharma
16-Oct-15SBBP2.50$10.00$25.0080.0%$20.00YesLink199618.70$187.021.2$212.00Phase IIIrare diseasesGOEndocrine
87
Cerecor14-Oct-15CERC4.00$6.50$26.00Link20114.63$30.18.6$56.10Phase IINoneMOA CNS
88
CytomX Therapeutics07-Oct-15NorCalCTMX6.67$12.00$80.0418.8%$15.05Link201028.23$338.834.9$418.80
Preclinical
Probody MabsPAVMOA cancer
89
Aclaris06-Oct-15ACRS5.00$11.00$55.0027.3%$15.02YesLink201214.40$158.419.4$213.40Phase IINoneDerm
90
Edge Therapeutics30-Sep-15EDGE7.32$11.00$80.5229.7%$23.91Link200920.18$222.027.5$302.50Phase II
Biodegradable polymers
GOrare CNS
91
Synlogic (Mirna)30-Sep-15MIRN6.25$7.00$43.7538.9%$17.02Link200713.85$97.020.1$140.70Phase ImicroRNAIOCGMOA cancer
92
Nabriva Therapeutics17-Sep-15NBRV9.00$10.25$92.2545.5%$41.97YesLink200510.80$110.719.8$202.95Phase IINoneInfection
93
RegenXbio16-Sep-15RGNX6.30$22.00$138.60Link200819.10$420.225.4$558.80
Preclinical
Gene TherapyIOCGCNS & metabolic
94
Benitec Biopharma18-Aug-15BNTC1.50$9.21$13.82Link19955.80$53.47.3$67.23Phase I/IIGene TherapyIOCGHCV
95
Global Blood11-Aug-15NorCalGBT6.00$20.00$120.00Link201121.80$436.027.8$556.00Phase I/IINoneSickle cell
96
Aimmune Therapeutics05-Aug-15NorCalAIMT10.00$16.00$160.0015.6%$24.96Link201130.70$491.240.7$651.20Phase IINoneAllergies
97
Intec Pharma04-Aug-15NTEC5.00$6.00$30.00Link20005.80$34.810.8$64.80Phase IIDrug deliveryParkinsons
98
Zynerba Pharm04-Aug-15ZYNE3.00$14.00$42.0028.6%$12.01YesLink20075.70$79.88.7$121.80
Preclinical
Drug deliverycannabinoids
99
vTv Therapeutics29-Jul-15VTVT7.81$15.00$117.1521.3%$24.95Link199824.99$374.932.8$492.00Phase III
Translational peptides
PAV
Alzheimers & diabetes
100
NantKwest27-Jul-15SoCalNK8.30$25.00$207.5026.8%$55.61Link200270.60$1,765.078.9$1,972.50Phase IImmunotherapyIOCGMOA cancer
Loading...
Main menu